Indonesia Penalizes Kalbe Over Suspected Drug Mix-Up Deaths
This article was originally published in PharmAsia News
Indonesia’s food and drug agency has ordered the country’s largest pharmaceutical company, Kalbe Farma, to suspend production of some of its drugs over a suspected label mix-up that led to the death of two patients.
You may also be interested in...
A new economic stimulus package from the Indonesian government that includes allowing up to 100% foreign ownership in the pharmaceutical and health sectors has been welcomed by the multinational industry.
An edict by a top Muslim council in Indonesia that the country’s national health insurance does not follow Islamic sharia law principles has sparked debate in the world’s most populous Muslim-majority country.
Indonesia’s national health insurance operator is seeking an increase in premiums as it struggles with deficits amid soaring claims within the system.